Thousand Oaks · Seed–Late Stage · 6 people tracked
Investment thesis
Through its Start-Up Network Program, Amgen sponsors life sciences incubators in key biotech innovation clusters and, in alignment with Amgen Ventures, provides funding and scientific support to early-stage life sciences and biotech start-ups. Since 2015 the program has supported over 20 companies, offering mentoring, scientific interaction, networking, potential collaboration, and access to innovation within the incubator community through a competitive selection process.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from curated & public directories
What they invest in
from 6 of 6 portfolio companiesBiotech ×4Deep Tech ×3AI & Machine Learning ×2Healthtech ×2Medical Devices ×2Digital Health ×1
HQs:United States×5
Investments · 6 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 13 dated
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)Jeffrey Verboon(Founding Scientist, Computational Biology)Ansu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Co-founder)
Co-investors8VCAndreessen HorowitzArtis VenturesGlobal BioAccess FundHAWKTAILPfizer Venture Investments+6 more
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.
AI & Machine LearningBiotechDeep TechDigital Health
Sriram Subramaniam(Founder)in
Co-investorsAir Street CapitalLux CapitalObvious VenturesLeaps by Bayer
HealthtechSan Carlos, US
Hugh Y. Rienhoff(Executive Officer, Director)Laura G. Eichorn(Executive Officer)
BoardPatrick Heron(Director)inDennis Henner(Director)Alan Sachs(Director)
Co-investorsClarus VenturesFrazier Healthcare PartnersFrazier Life Sciences
HealthtechPhoenix, US
MARK L. WHITEHOUSE(Executive Officer)MITCHELL A. FOSTER(Executive Officer, Director, Promoter)Mark Whitehouse(Executive Officer, Director, Promoter)Nicholas Theodore(Director)Mitchell Foster(Executive Officer, Director, Promoter)Joel Barthelemy(Director)
Co-investorsGrayhawk CapitalAZ Venture Capital Inc.NOVA PrimeQuesta CapitalXcellerant Ventures
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)Roet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)Jason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)
Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+6 more
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
BiotechBoston, US
Tasuku Kitada(Executive Officer, Director, Promoter)inJacob Becraft(Executive Officer, Director, Promoter)inSamta Kundu(Executive Officer)
BoardJeb Keiper(Director)Ala Alenazi(Director)Pegah Ebrahimi(Director)
Co-investorsJIC Venture Growth InvestmentsKinnevikPlayground GlobalANRIFPVICONIQ+2 more
Portfolio news
latest coverage across their companiesCartography Biosciences · finsmes.com · May 7, 2026
Quralis · nasdaqprivatemarket.com · Apr 3, 2026
Mindset Medical · finsmes.com · Oct 9, 2025
Frequently asked questions
- What stage does Amgen Ventures invest at?
- Amgen Ventures invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Amgen Ventures's typical check size?
- Amgen Ventures typically writes checks of $1M – $3M.
- What sectors does Amgen Ventures focus on?
- Amgen Ventures focuses on Biotech, Healthtech.
- Where is Amgen Ventures located?
- Amgen Ventures is headquartered in Thousand Oaks, US.
Media · Podcasts & interviews
from their channelIgG4-RD Explained: From Delayed Diagnosis to Improving Care
Amgen
AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research
Amgen
Images
Similar investors
Legendary Ventures is a venture capital firm focused on consumer, retail, and technology (CRT) companies, combining the expertise of venture capitalists and retail executives to support portfolio companies and identify acquisition partners.
Speedinvest operates a Portfolio Success program that connects its 400+ portfolio startups with customers, follow-on investors, industry experts, talent, discounted tools, and fellow founders across Europe, the Middle East, Africa, and beyond.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.
Celesta Capital is a venture capital firm that invests in deep tech companies at the forefront of science and engineering.
New Science Ventures (NSV) is a venture capital firm based in Connecticut and London that backs companies applying novel scientific approaches in the life sciences and information technology sectors.